TY - JOUR
AU - Reddy, S. Ashwin
AU - Newman, Joseph
AU - Leavy, Olivia C.
AU - Ghani, Hakim
AU - Pepke-Zaba, Joanna
AU - Cannon, John E.
AU - Sheares, Karen K.
AU - Taboada, Dolores
AU - Bunclark, Katherine
AU - Lawrie, Allan
AU - Sudlow, Cathie L.
AU - Berry, Colin
AU - Wild, James M.
AU - Mitchell, Jane A.
AU - Quint, Jennifer K.
AU - Rossdale, Jennifer
AU - Price, Laura
AU - Howard, Luke S.
AU - Wilkins, Martin
AU - Sattar, Naveed
AU - Chowienczyk, Philip
AU - Thompson, Roger
AU - Wain, Louise V.
AU - Horsley, Alex
AU - Ho, Ling-Pei
AU - Chalmers, James D.
AU - Marks, Michael
AU - Poinasamy, Krisnah
AU - Raman, Betty
AU - Harris, Victoria C.
AU - Houchen-Wolloff, Linzy
AU - Brightling, Christopher E.
AU - Evans, Rachael A.
AU - Toshner, Mark R.
PY - 2024
DA - August
TI - Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies
JO - European Respiratory Journal
VL - 64
IS - 2
DO - https://doi.org/10.1183/13993003.01742-2023
AB - Background Pulmonary embolism (PE) is a well-recognised complication of coronavirus disease 2019 (COVID-19) infection, and chronic thromboembolic pulmonary disease with and without pulmonary hypertension (CTEPD/CTEPH) are potential life-limiting consequences. At present the burden of CTEPD/ CTEPH is unclear and optimal and cost-effective screening strategies yet to be established.
PB - ERS Publications
UR - https://discovery.dundee.ac.uk/en/publications/da25829d-c8aa-421a-81d0-0446c1b5e730
KW - Coronavirus (COVID-19)
ER